 cis-platinum ototoxicity children ototoxicity cis-platinum clinical outline audiologic evaluation patients drug practical approach problem audiograms pediatric patients cis-platinum therapy Eleven patients auditory brain-stem response ABR audiometry several limitations modality Fourteen children underwent initial ABR testing pure-tone audiograms patients hearing pure-tone audiometry Various factors patient age cis-platinum dosage cranial radiation exposure apparent effect patients susceptible changes administration cis-platinum proportion patients hearing loss successive dosing severity hearing loss Prior exposure cranial radiation development loss cis-platinum therapy Guidelines use clinical audiometry screening pediatric oncology patients